Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1995-7-20
|
pubmed:abstractText |
The susceptibilities of 216 strains of Neisseria gonorrhoeae to a new fluoroquinolone, CP-99,219 were determined. For strains for which the MICs of ciprofloxacin were < or = 0.06 microgram/ml, the MICs at which 90% of the isolates are inhibited (MIC90s) of CP-99,219, ciprofloxacin, and ofloxacin were 0.008, 0.015, and 0.03 microgram/ml, respectively. For strains for which the MICs of ciprofloxacin were 0.125 to 0.5 microgram/ml, the MIC90s of CP-99,219, ciprofloxacin, and ofloxacin were 0.06, 0.25, and 0.5 microgram/ml, respectively. For strains for which the MICs of ciprofloxacin and ofloxacin were 2.0 micrograms/ml, the MIC of CP-99,219 was 0.25 microgram/ml.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/7786010-1416851,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7786010-1736071,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7786010-1967354,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7786010-1967452,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7786010-7811045,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7786010-7811047,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7786010-7979312,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7786010-8141573,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7786010-8345839
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0066-4804
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
987-9
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading | |
pubmed:year |
1995
|
pubmed:articleTitle |
In vitro activity of a new fluoroquinolone, CP-99,219, against strains of Neisseria gonorrhoeae.
|
pubmed:affiliation |
Division of Sexually Transmitted Diseases Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
|
pubmed:publicationType |
Journal Article
|